Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Oral Antidiabetic Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Oral Antidiabetic Drugs Market, by Drug, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oral Antidiabetic Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oral Antidiabetic Drugs Market Dynamics
3.1. Oral Antidiabetic Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Oral Antidiabetic Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Oral Antidiabetic Drugs Market, by Drug
5.1. Market Snapshot
5.2. Global Oral Antidiabetic Drugs Market by Drug, Performance - Potential Analysis
5.3. Global Oral Antidiabetic Drugs Market Estimates & Forecasts by Drug 2017-2027 (USD Billion)
5.4. Oral Antidiabetic Drugs Market, Sub Segment Analysis
5.4.1. Biguanides
5.4.2. Alpha-glucosidase inhibitors
5.4.3. Dopamine -D2 Receptor Agonist
5.4.4. Sodium - glucose Cotransport -2 (SGLT-2) inhibitor
5.4.5. Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
5.4.6. Sulfonylureas
5.4.7. Meglitinides
Chapter 6. Global Oral Antidiabetic Drugs Market, Regional Analysis
6.1. Oral Antidiabetic Drugs Market, Regional Market Snapshot
6.2. North America Oral Antidiabetic Drugs Market
6.2.1. U.S. Oral Antidiabetic Drugs Market
6.2.1.1. Drug breakdown estimates & forecasts, 2017-2027
6.2.2. Canada Oral Antidiabetic Drugs Market
6.3. Europe Oral Antidiabetic Drugs Market Snapshot
6.3.1. U.K. Oral Antidiabetic Drugs Market
6.3.2. Germany Oral Antidiabetic Drugs Market
6.3.3. France Oral Antidiabetic Drugs Market
6.3.4. Spain Oral Antidiabetic Drugs Market
6.3.5. Italy Oral Antidiabetic Drugs Market
6.3.6. Rest of Europe Oral Antidiabetic Drugs Market
6.4. Asia-Pacific Oral Antidiabetic Drugs Market Snapshot
6.4.1. China Oral Antidiabetic Drugs Market
6.4.2. India Oral Antidiabetic Drugs Market
6.4.3. Japan Oral Antidiabetic Drugs Market
6.4.4. Australia Oral Antidiabetic Drugs Market
6.4.5. South Korea Oral Antidiabetic Drugs Market
6.4.6. Rest of Asia Pacific Oral Antidiabetic Drugs Market
6.5. Latin America Oral Antidiabetic Drugs Market Snapshot
6.5.1. Brazil Oral Antidiabetic Drugs Market
6.5.2. Mexico Oral Antidiabetic Drugs Market
6.6. Rest of The World Oral Antidiabetic Drugs Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Takeda Pharmaceutical Company Ltd.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Pfizer Inc.
7.2.3. Eli Lilly and Company
7.2.4. Janssen Pharmaceutica
7.2.5. Astellas Pharma
7.2.6. Boehringer Ingelheim Group
7.2.7. Merck & Co., Inc.,
7.2.8. AstraZeneca plc
7.2.9. Novartis International AG
7.2.10. Sanofi S.A.
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption



List of Figures


FIG 1. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA ORAL ANTIDIABETIC DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE ORAL ANTIDIABETIC DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC ORAL ANTIDIABETIC DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA ORAL ANTIDIABETIC DRUGS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET, REPORT SCOPE
TABLE 2. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY DRUG 2017-2027 (USD BILLION)
TABLE 4. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 5. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 6. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL ORAL ANTIDIABETIC DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. U.S. ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. U.S. ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 16. U.S. ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 17. CANADA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 18. CANADA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 19. CANADA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. UK ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 21. UK ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 22. UK ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. GERMANY ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 24. GERMANY ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 25. GERMANY ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. ROE ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 27. ROE ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 28. ROE ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. CHINA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 30. CHINA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 31. CHINA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. INDIA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 33. INDIA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 34. INDIA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. JAPAN ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 36. JAPAN ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 37. JAPAN ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. ROAPAC ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 39. ROAPAC ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 40. ROAPAC ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. BRAZIL ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 42. BRAZIL ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 43. BRAZIL ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. MEXICO ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 45. MEXICO ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 46. MEXICO ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. ROLA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 48. ROLA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 49. ROLA ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROW ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 51. ROW ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 52. ROW ORAL ANTIDIABETIC DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ORAL ANTIDIABETIC DRUGS MARKET
TABLE 54. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ORAL ANTIDIABETIC DRUGS MARKET
TABLE 55. YEARS CONSIDERED FOR THE STUDY
TABLE 56. EXCHANGE RATES CONSIDERED